Journal of the Neurological Sciences
Volume 229 , Pages 27-36 , 15 March 2005

Noninfarct vascular dementia and Alzheimer dementia spectrum

References 

  1. Emery VOB, Gillie E, Ramdev P. Vascular dementia redefined. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 1994;p. 162–194
  2. Emery VOB, Gillie E, Smith J. Reclassification of the vascular dementias. Int. Psychogeriatr. 1996;8:33–61
  3. Emery VOB, Gillie E, Smith J. Interface between vascular dementia and Alzheimer syndrome: nosologic redefinition. Ann. N. Y. Acad. Sci. 2000;903:229–238
  4. Emery VOB, Gillie E, Smith J. Noninfarct vascular dementia. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 263–290
  5. Emery VOB. Retrophylogenesis of memory in dementia of the Alzheimer type: a new evolutionary memory framework. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 177–238
  6. Emery, VOB Pseudodementia: a theoretical and empirical discussion. Western Reserve Geriatric Education Center Monograph Series. Cleveland: Case Western Reserve University School of Medicine, 1988.
  7. Campbell S, Stanley J. Experimental and quasi-experimental designs for research. Chicago: Rand McNally; 1969;
  8. Emery VOB, Oxman T. The spectra of the dementias. In:  Emery VOB,  Oxman T editor. Dementia: presentation, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 490–522
  9. Emery VOB, Gillie E, Ramdev P. Noninfarct vascular dementia: a new subtype of dementing disorder. J. Clin. Geropsychol. 1996;2:197–213
  10. Pirttila T, Erkinjuntti T, Hachinski V. Vascular dementia and Alzheimer disease: differential diagnosis. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 306–335
  11. Wright R, Kokmen E. Gradually progressive dementia without discrete cerebrovascular events in a patient with Sneddon's syndrome. Mayo Clin. Proc. 1999;74:57–61
  12. Mayer-Gross W, Slater E, Roth M. Clinical psychiatry. London: Bailliere, Tindall and Cassell; 1960;
  13. Hachinski V, Lassen N, Marshall J. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet. 1974;2:207–210
  14. Roman G, Tatemichi T, Erkinjuntti T, Cummings J, Masden J, Garcia J, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–260
  15. Erkinjuntti T. Vascular dementia: challenge of clinical diagnosis. Int. Psychogeriatr. 1997;9:51–58
  16. Hachinski V, Iliff L, Phil M, Zilhka E, Duboulay G, McAllister V, et al. Cerebral blood flow in dementia. Arch. Neurol. 1975;32:632–637
  17. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Washington, (DC): American Psychiatric Association; 1980;
  18. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Washington, (DC): American Psychiatric Association; 1987;
  19. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Washington, (DC): American Psychiatric Association; 1994;
  20. World Health Organization . The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992;
  21. World Health Organization . The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993;
  22. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Washington, (DC): American Psychiatric Association; 2000;
  23. Reisberg B, Burns A, Brodaty H, Eastwood R, Rossor M, Sartorius N, et al. Diagnosis of Alzheimer disease. Int. Psychogeriatr. 1997;9:11–38
  24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34:939–944
  25. Assal F, Cummings J. Cortical and frontosubcortical dementias: differential diagnosis. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 239–262
  26. Sjogren M, Wallin A, Blennow K. Clinical subgroups of Alzheimer disease. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 139–155
  27. Kobayashi S. The relationship of hypertension to vascular dementia. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 291–306
  28. National Institute of Neurological and Communicative Disorders and Stroke . A classification and outline of cerebrovascular disorders II. Stroke. 1975;(6):564–616
  29. Folstein M, Folstein S, McHugh P. “Mini-mental state”: a practical method for grading the mental state of patients. J. Psychiatr. Res. 1975;12:189–198
  30. Mattis S. Dementia rating scale. Odessa, (FL): Psychological Assessment Resources; 1988;
  31. Kertesz A. Western aphasia battery. New York: Grune and Stratton; 1982;
  32. Kaplan E, Goodglass H, Weintraub S. Boston naming test. Philadelphia: Lea and Febinger; 1983;
  33. Emery VOB. Language functioning. In:  Morris R editors. The cognitive neuropsychology of Alzheimer-type dementia. Oxford: Oxford University Press; 1996;p. 166–193
  34. Emery VOB. Language impairment in dementia of the Alzheimer-type: a hierarchical decline?. Int. J. Psychiatry Med. 2000;30:145–164
  35. Emery VOB. Language and aging. Exp. Aging Res. Monogr. 1985;11(1):
  36. Kirshner H. Progressive aphasia, frontotemporal dementia, and other “focal dementias”. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 156–176
  37. Emery VOB, Breslau L. The problem of naming in SDAT: a relative deficit. Exp. Aging Res. 1988;14:181–193
  38. Emery VOB, Oxman T. Depressive dementia: a “prepermanent intermediate-stage dementia” in the long-term disease course of permanent dementia?. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 361–397
  39. Luria A. Higher cortical functions in man. New York: Basic Books; 1980;
  40. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. Washington, (DC): American Psychiatric Association; 1968;
  41. Ross R. Mechanisms of disease: atherosclerosis: an inflammatory disease. N. Engl. J. Med. 1999;340:115–126
  42. Ross R. The pathogenesis of atherosclerosis. Nature. 1993;362:801–809
  43. Ross R. Atherosclerosis: a defense mechanism gone awry. Am. J. Pathol. 1993;143:987–1002
  44. Lukacs N, Ward P. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv. Immunol. 1996;62:257–304
  45. Johnson R. What mediates progressive glomerulosclerosis?. Am. J. Pathol. 1997;151:1179–1181
  46. Tormey V, Faul J, Leonard C, Burke C, Dilmec A, Poulter L. T-cell cytokines may control the balance of functionally distinct macrophage populations. Immunology. 1997;90:463–469
  47. McGeer E, McGeer P. Neural inflammatory mechanisms in Alzheimer syndrome. In:  Emery VOB,  Oxman T editor. Dementia: presentations, differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 2003;p. 121–138
  48. Snowdon D. Aging with grace. New York: Bantam Books; 2001;
  49. McGeer P, McGeer E. Autotoxicity and Alzheimer disease. Arch. Neurol. 2000;57:789–790
  50. McGeer P, Schultzer M, McGeer E. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies. Neurology. 1996;47:425–432
  51. McGeer P, Akiyama H, Itagaki S. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 1989;16:516–527
  52. McGeer P, McGeer E. Polymorphisms in inflammatory genes enhance the risk of Alzheimer disease. Arch Neurol (in press).
  53. Rogers J. Anti-inflammatory approaches to the treatment of Alzheimer's disease. In: Excerpta Medica Medical Communications  editors. Postgraduate dementia course: heterogeneity of Alzheimer's disease. Amsterdam: Excerpta Medica; 1997;p. 32–33
  54. Kivipelto M, Helkala E, Laakso M. Midlife vascular risk factors and late-life Alzheimer disease: a longitudinal population based study. Br. Med. J. 2001;322:1447–1551
  55. Kalaria R, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis. Assoc. Disord. 1999;13:S115–S123
  56. Erkinjuntti T, Hachinski V, Sulkava R. Alzheimer disease and vascular dementia: differential diagnosis. In:  Emery VOB,  Oxman T editor. Dementia: presentations differential diagnosis, and nosology. Baltimore: Johns Hopkins University Press; 1994;p. 208–232
  57. Groves W, Brandt J, Steinberg M, Warren A, Rosenblatt A, Baker A, et al. Vascular dementia and Alzheimer's disease: is there a difference? A comparison of symptoms by disease duration. J. Neuropsychiatry Clin. Neurosci. 2000;12:305–315

PII: S0022-510X(04)00438-1

doi: 10.1016/j.jns.2004.11.016

Journal of the Neurological Sciences
Volume 229 , Pages 27-36 , 15 March 2005

Article Tools